Rankings
▼
Calendar
PTCT FY 2016 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$5B
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$83M
+124.9% YoY
Gross Profit
-$35M
-42.2% margin
Operating Income
-$132M
-159.7% margin
Net Income
-$142M
-171.8% margin
EPS (Diluted)
$-4.17
Cash Flow
Operating Cash Flow
-$104M
Free Cash Flow
-$105M
Stock-Based Comp.
$35M
Balance Sheet
Total Assets
$269M
Total Liabilities
$150M
Stockholders' Equity
$120M
Cash & Equivalents
$232M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$83M
$37M
+124.9%
Gross Profit
-$35M
-$85M
+58.9%
Operating Income
-$132M
-$167M
+21.0%
Net Income
-$142M
-$170M
+16.6%
← FY 2015
All Quarters
Q1 2016 →